Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: An analysis of Intracoronary Abciximab and Aspiration Thrombectomy in Patients with Large Anterior Myocardial Infarction (INFUSE-AMI)

American Heart Journal

Volumn 169, Issue 1, 2015, Pages 86-93

  Tomey, Matthew I ^a   Mehran, Roxana ^a,b   Brener, Sorin J ^b,c   Maehara, Akiko ^b,d   Witzenbichler, Bernhard ^e   Dizon, José M ^d   El Omar, Magdi ^f   Xu, Ke ^b,c   Gibson, Michael ^g   Stone, Gregg W ^b,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

^d Department of Medicine   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Manchester Heart Centre   (United Kingdom)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CARDIOVASCULAR MORTALITY; CATHETER; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; THROMBUS ASPIRATION; ANTERIOR WALL MYOCARDIAL INFARCTION; COMPARATIVE STUDY; COMPLICATION; HEART FAILURE; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; THROMBECTOMY; TREATMENT OUTCOME;

AGED; ANTERIOR WALL MYOCARDIAL INFARCTION; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SEX FACTORS; THROMBECTOMY; TREATMENT OUTCOME;

EID: 84924369201     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.019     Document Type: Article

References (22)

1. Jneid H, Fonarow GC, Cannon CP, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008;118:2803-10.
2. Cheng CI, Yeh KH, Chang HW, et al. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 2004;126:47-53.
3. Benamer H, Tafflet M, Bataille S, et al. Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry. EuroIntervention 2011;6:1073-9.
4. De Luca G, Gibson CM, Gyongyosi M, et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis 2010;30:342-6.
5. Kralev S, Hennig O, Lang S, et al. Sex-based differences in clinical and angiographic outcomes in patients with ST-elevation myocardial infarction treated with concomitant use of glycoprotein IIb/IIIa inhibitors. Cardiol J 2010;17:580-6.
6. Pu J, Shan P, Ding S, et al. Gender differences in epicardial and tissue-level reperfusion in patients undergoing primary angioplasty for acute myocardial infarction. Atherosclerosis 2011;215:203-8.
7. Gevaert SA, De Bacquer D, Evrard P, et al. Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry. BMC Nephrol 2013;14:62.
8. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med 2005;353:671-82.
9. Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007;115:833-9.
10. Eitel I, Desch S, de Waha S, et al. Sex differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction: advances in cardiovascular imaging. Circ Cardiovasc Imaging 2012;5:119-26.
11. Gibson CM, Maehara A, Lansky AJ, et al. Rationale and design of the INFUSE-AMI study: a 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J 2011;161:478-86. [e7].
12. Stone GW, Dixon SR, Grines CL, et al. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol 2007;100:1370-5.
13. Heer T, Schiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002;89:511-7.
14. Cohen M, Gensini GF, Maritz F, et al. The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction. J Thromb Thrombolysis 2005;19:155-61.
15. RaoV, Safdar B, Parkosewich J, etal. Improvements in time to reperfusion: do women have an advantage? Crit Pathw Cardiol 2009;8:38-42.
16. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56: 786-94.
17. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631-8.
18. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109:1223-5.
19. Antoniucci D, Valenti R, Migliorini A, et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002;89:1248-52.
20. De Luca G, Suryapranata H, Zijlstra F, et al. Symptom-onset-to-balloon time andmortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-7.
21. Brodie BR, Stone GW, Cox DA, et al. Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Am Heart J 2006;151:1231-8.
22. Menees DS, Peterson ED, Wang Y, et al. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 2013;369:901-9.